Ioannis Isaias

Affiliations: 
Julius-Maximilans-Universität Würzburg, Würzburg, Bayern, Germany 
Google:
"Ioannis Isaias"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Todisco M, Alfonsi E, Isaias IU, et al. (2019) Vocal cord electromyographic correlates of stridor in multiple system atrophy phenotypes. Parkinsonism & Related Disorders. 70: 31-35
Pozzi NG, Canessa A, Palmisano C, et al. (2019) Freezing of gait in Parkinson's disease reflects a sudden derangement of locomotor network dynamics. Brain : a Journal of Neurology. 142: 2037-2050
Arlotti M, Palmisano C, Minafra B, et al. (2019) Monitoring subthalamic oscillations for 24 hours in a freely moving Parkinson's disease patient. Movement Disorders : Official Journal of the Movement Disorder Society
Palmisano C, Brandt G, Pozzi NG, et al. (2019) Sit-to-walk performance in Parkinson's disease: A comparison between faller and non-faller patients. Clinical Biomechanics (Bristol, Avon). 63: 140-146
Reich MM, Horn A, Lange F, et al. (2019) Probabilistic mapping of the antidystonic effect of pallidal neurostimulation: a multicentre imaging study. Brain : a Journal of Neurology
Bolzoni F, Esposti R, Marchese SM, et al. (2018) Disrupt of Intra-Limb APA Pattern in Parkinsonian Patients Performing Index-Finger Flexion. Frontiers in Physiology. 9: 1745
Casarotto S, Turco F, Comanducci A, et al. (2018) Excitability of the supplementary motor area in Parkinson's disease depends on subcortical damage. Brain Stimulation
Turco F, Canessa A, Olivieri C, et al. (2018) Cortical response to levodopa in Parkinson's disease patients with dyskinesias. The European Journal of Neuroscience
Arnulfo G, Pozzi NG, Palmisano C, et al. (2018) Phase matters: A role for the subthalamic network during gait. Plos One. 13: e0198691
Sulzer D, Cassidy C, Horga G, et al. (2018) Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease. Npj Parkinson's Disease. 4: 11
See more...